Tourette Syndrome in Adolescence
Conditions
Brief summary
In children with neurodevelopmental disorders, adolescence is usually associated with a reshaping of the clinical picture and symptomatology. Tourette syndrome (TS) is a paradigmal neurodevelopmental syndrome characterised by involuntary paroxysmal movements (motor tics) and vocalisation (vocal tics) often associated with various psychiatric disorders. The neuronal and cognitive mechanisms associated with TS symptoms improvement during adolescence, or the persistence in adulthood remains unknown, and this is what we aim to address in this study.
Detailed description
Thus, the aims of the present project is threefold: Aim 1: To evaluate the maturation of cognitive functions in adolescents with TS compared to typically developing adolescents. To achieve this aim, three distinct cognitive dimensions will be assessed in all subjects (patients and controls): (i) reward sensitivity and habit formation; (ii) cognitive impulsivity and action control and (iii) self-agency. Aim 2: To identify neuronal correlates of cognitive function and brain development in health and disease. To achieve this aim, we will use a combined behavioural (as described in Aim 1), (i) neuroimaging and (ii) TMS approaches. Aim 3: To predict clinical outcome . In this part of the project we aim to identify behavioural, imaging or neurophysiological markers of clinical outcome in patients with TS.
Interventions
Testing on cognitive computerized tasks
Brain MRI scans
Measure of the cortical inhibitory capacity using TMS measures
Sponsors
Study design
Intervention model description
Between group comparison
Eligibility
Inclusion criteria
* Tourette syndrome * Ages 13 - 18 * Acceptance to perform the Brain MRI * Acceptance to perform the cognitive testing * Acceptance to perform the TMS measures
Exclusion criteria
* Learning disability * Incompatibility with MRI procedure (metal body implants, pregnancy)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Behavioral test main outcome measures [1] | from 16 to 20 months | reaction times |
| Behavioral test main outcome measures [2] | from 16 to 20 months | discounting factor |
| Behavioral test main outcome measures [3] | from 16 to 20 months | number of premature responses |
| Behavioral test main outcome measures [4] | from 16 to 20 months | agency composite scores |
| Brain MRI scan measures | from 16 to 20 months | whole brain structural connectivity, whole brain functional connectivity, brain cortical and subcortical structures volumes and morphology |
| Transcranial magnetic stimulation | from 16 to 20 months | Short Intracortical Inhibition (SICI) scores |
Countries
France
Contacts
Institut National de la Santé Et de la Recherche Médicale, France